| 2004 |
Pharma Industries is re-branded to unify Interphil, Interthai and Interpharma Manufacturing Vietnam under a single brand. |
| 2003 |
Product development cooperation with SwissCaps and Ethypharm.
Interthai commences export to Japan.
Revenue reaches US$ 50 million. |
| 2002 |
The Vietnamese market is penetrated with acquisition of the Novartis manufacturing plant.
Major investments in process automation transpire at Interphil.
|
| 2001 |
Interphil expands its export activities to ASEAN. |
| 2000 |
Interphil commences export to Australia. |
| 1999 |
Interphil obtains AustraliaTGA certification. |
| 1998 |
Interphil opens Beta Lactam facility, formerly a Novartis manufacturing plant.
Interphil commences export to Taiwan.
Interthai is spun-off and becomes a stand-alone company.
|
| 1997 |
The Asian Financial Crisis serves as a catalyst for the closure of many multi-national pharmaceutical manufacturing plants throughout Asia Pacific. |
| 1995 |
Interphil opens new plant in Canlubang. |
| 1991 |
Interphil goes public on the Philippines Stock Exchange. |
| 1978/79 |
Interphil builds a new plant in Sucat (southern suburb of Manila). |
| 1978 |
Pharma Industries and Muller & Phipps merge and form Interphil. |
| 1974 |
Pharma Labs, Thailand, a division of FE Zuellig was born. |
| 1950's |
Pharma Industries, a Zuellig-owned company sets up a manufacturing operation in the Philippines. |
| 1940's |
Muller & Phipps, a US-owned company sets up a manufacturing operation in the Philippines. |
